Long-term Steroid Use Nearly Doubles Death Risk Across Multiple Diseases
Major analysis of 51,380 patients reveals chronic oral steroids increase mortality by 87%, with cardiovascular disease as leading cause of death.
Summary
A comprehensive analysis of over 51,000 patients found that chronic oral steroid use increases death risk by 87% compared to the general population. Higher doses and longer treatment duration significantly amplified this risk. Cardiovascular disease emerged as the leading cause of death at 25.6%, followed by cancer at 15.7% and infections at 13.4%. The highest mortality rates occurred in patients with inflammatory diseases and vasculitis. Cumulative doses above 5 grams of prednisolone equivalent and daily doses exceeding 5mg were independently linked to increased mortality, emphasizing the importance of careful steroid management and cardiovascular protection strategies.
Detailed Summary
This landmark meta-analysis reveals alarming mortality risks associated with chronic oral steroid therapy, a treatment used by millions worldwide for conditions ranging from arthritis to autoimmune diseases. The findings have significant implications for anyone on long-term steroid treatment and their healthcare providers.
Researchers analyzed 116 studies encompassing 128 patient groups and 51,380 individuals receiving chronic oral glucocorticoids. Using systematic review methodology, they calculated standardized mortality ratios and examined dose-response relationships across different diseases and treatment regimens.
The results showed an 87% increase in death risk compared to the general population, with an overall death rate of 12%. Patients with inflammatory diseases faced the highest mortality at 30%, while those with vasculitis had an 18% death rate. Crucially, the study identified clear dose-dependent relationships: cumulative doses exceeding 5 grams of prednisolone equivalent, daily doses above 5mg, and higher initial doses all independently increased mortality risk.
Cardiovascular disease accounted for over a quarter of deaths, highlighting the critical need for heart health monitoring in steroid users. Cancer and infections were also major contributors to mortality. These findings suggest that patients on chronic steroids should prioritize cardiovascular protection through lifestyle modifications, regular monitoring, and potentially preventive medications.
While the study couldn't definitively prove causation due to underlying disease severity and other confounding factors, the consistent dose-response relationships strongly suggest steroids themselves contribute to increased mortality. This research supports careful steroid management and targeted risk mitigation rather than avoiding necessary treatment.
Key Findings
- Chronic oral steroid use increases death risk by 87% compared to general population
- Cardiovascular disease causes 25.6% of deaths in chronic steroid users
- Daily doses above 5mg and cumulative doses over 5g significantly increase mortality
- Patients with inflammatory diseases face highest death rates at 30%
- Infections account for 13.4% of deaths, emphasizing immune system compromise
Methodology
Systematic review and meta-analysis of 116 studies covering 128 cohorts with 51,380 patients receiving chronic oral glucocorticoids. Studies spanned from 1945 to March 2019, using random-effects meta-analysis to calculate standardized mortality ratios and dose-response relationships across different disease groups and exposure metrics.
Study Limitations
Causal relationships remain uncertain due to confounding by underlying disease severity and indication bias. Limited data on disease-specific severity markers and potential exposure misclassification may affect results. Most studies were observational, preventing definitive conclusions about direct steroid causation versus disease-related mortality.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.